A total of five potentially targetable tumor antigens were identified (PTPRC, SIGLEC10, CARD11, LILRB1, ADAMDEC1); high antigen expression was associated with prolonged OS and DFS, as well as higher tumor infiltration by antigen-presenting cells. This evidence concerns the gene SIGLEC10 and neoplasm.